Today: 13 May 2026
SGX stock price today: Singapore Exchange shares edge up after January trading surge
10 February 2026
1 min read

SGX stock price today: Singapore Exchange shares edge up after January trading surge

Singapore, Feb 10, 2026, 15:20 SGT — Regular session

  • Shares of Singapore Exchange edged up a bit during the afternoon session.
  • January’s numbers are in for cash equities, ETFs, and derivatives, and investors are working through the fresh activity data.
  • Attention now turns to the dividend schedule and if trading strength extends into February.

Singapore Exchange Ltd’s shares ticked up 0.1% to S$18.12 in Tuesday afternoon trading, sticking close to their S$18.00–S$18.17 range for the day.

SGX’s monthly operating snapshot drops early, offering a clear look at whether trading is holding up. That figure is key for the bourse operator—its fee income tracks closely with turnover across cash equities, ETFs, and derivatives.

SGX remains in focus after Reuters highlighted the exchange’s best half-year profit since its 2000 debut and a raised interim dividend, both bolstered by heavy trading as investors shifted positions in choppy markets.

Singapore Exchange reported that January’s stock-market turnover hit S$34.6 billion, up 66% year-on-year. Securities daily average value notched a 58% gain to S$1.65 billion. Over on the derivatives side, traded volume jumped 34% to 32.1 million contracts—the highest level since March 2020. Daily average volume for derivatives picked up 27%, coming in around 1.6 million contracts.

The exchange highlighted a surge in ETF turnover, with both retail and institutional investors stepping up activity. Appetite spilled over from just the benchmark names as more stocks posted daily turnover north of S$1 million. This month saw the Monetary Authority of Singapore and SGX Stock Exchange kick off the Value Unlock programme. Secondary fundraising touched S$963 million, and two new companies joined Catalist, according to The Business Times.

Still, that January surge isn’t a sure thing for the months ahead. If volatility drops away, trading volumes tend to pull back fast. Much of SGX’s derivatives business hinges on cross-border hedging, especially in equity contracts and currencies linked to China.

On the listings front, the question is whether chatter in the pipeline will materialize into actual deals. Boustead’s Singapore unit got the green light for its planned UI Boustead REIT, aiming to hit the SGX. Premarketing kicks off this week, according to Reuters.

Management’s messaging hasn’t budged. On Feb. 5, SGX chief executive Loh Boon Chye described the group’s latest period as its “strongest half-year performance,” sticking to a 6% to 8% revenue growth goal for the medium-term, according to The Straits Times. Maybank’s Thilan Wickramasinghe, who oversees research and regional financials, downplayed the initial drop in shares post-earnings. He told the paper the move looked sentiment-driven, not based on fundamentals, and said the numbers suggest “strengthening momentum into the second half.” The Straits Times

SGX is set to go ex-dividend on Feb. 12 for its interim payout of S$0.11 per share, according to a corporate action notice. The record date lands one day later, Feb. 13, while investors can expect payment on Feb. 24.

Stock Market Today

  • Creative Media & Community Trust (CMCT): Among NASDAQ's Worst Performers in 2026
    May 13, 2026, 2:58 PM EDT. Creative Media & Community Trust Corporation (NASDAQ:CMCT) posted a Q1 2026 net loss of $34.7 million, or $70.52 per diluted share, reflecting two reverse 1-for-10 stock splits this year. The company's real estate portfolio showed mixed results: multifamily occupancy rose to 91.4% excluding new leases, while office leasing lagged at 73.1%, improved to 85.7% after excluding an underperforming asset. A major hotel renovation aims to boost performance. CMCT sold its "First Western" lending business for around $44.9 million in January, retired its recourse credit facility, and redeemed $396.2 million in preferred stock since late 2024. Despite potential, CMCT faces significant challenges. Investors may find better risk-reward in select AI stocks benefiting from tariffs and reshoring trends.

Latest articles

Palantir Stock Slides as Zelenskiy Meeting Puts War-AI Bet in Focus

Palantir Stock Slides as Zelenskiy Meeting Puts War-AI Bet in Focus

13 May 2026
Palantir shares fell 4.4% to $129.97 Wednesday as CEO Alex Karp met President Volodymyr Zelenskiy in Kyiv to discuss expanding AI use in Ukraine’s war effort. Kyiv’s Brave1 Dataroom project, launched with Palantir, is training AI models to intercept Russian drones. Russia fired at least 800 drones at Ukraine on Wednesday, killing six. Palantir’s U.S. government and commercial revenue surged in the first quarter.
Why Grab Holdings Stock Is Back Under Pressure After a Big Q1 Beat

Why Grab Holdings Stock Is Back Under Pressure After a Big Q1 Beat

13 May 2026
Grab shares fell 1.1% to $3.60 in New York after first-quarter revenue beat estimates, rising 24% to $955 million. Profit jumped to $120 million from $10 million a year earlier. Investors weighed strong results against Indonesia’s new 8% ride-hailing commission cap. Grab kept its 2026 revenue and adjusted EBITDA outlook unchanged.
SoFi Bought a Key IPO Access Tool. The Stock Is Still Telling a More Cautious Story

SoFi Bought a Key IPO Access Tool. The Stock Is Still Telling a More Cautious Story

13 May 2026
SoFi acquired PrimaryBid’s technology to expand IPO access for retail investors, confirmed by both companies. SoFi shares fell 2.9% to $15.44 after Truist cut its price target, citing concerns over loan and technology platforms. The acquisition follows a drop in technology-platform accounts and comes as SoFi reported strong first-quarter revenue and member growth. Terms of the deal were not disclosed.

Popular

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

12 May 2026
UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
Why Constellation Energy (CEG) stock is up today: new 380‑MW Texas data center deal
Previous Story

Why Constellation Energy (CEG) stock is up today: new 380‑MW Texas data center deal

RELX share price edges higher — what to watch before Thursday’s results
Next Story

RELX share price edges higher — what to watch before Thursday’s results

Go toTop